{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:27:18Z","timestamp":1788481638597,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec><jats:title>Purpose of review<\/jats:title><jats:p>Of the four musculoskeletal domains of psoriatic arthritis (PsA), the axial domain is the least studied. With the advent of targeted therapy that is efficacious in some but not all manifestations of spondyloarthritis (SpA), there is interest in understanding the similarities and differences between axial PsA (axPsA) and ankylosing spondylitis. Moreover, there is also interest in evaluating the axial domain in PsA clinical trials, domain that has traditionally been ignored in such studies. This review aims to summarize the current understanding of the differences between ankylosing spondylitis and axPsA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>Recent observational studies have shown that axPsA forms part of the SpA spectrum, flanked by peripheral PsA on one side and ankylosing spondylitis on the other. Thus, axial disease is more severe in ankylosing spondylitis, whereas peripheral disease is more severe in axPsA. However, the overall disease burden and impact is similar. The expression of axPsA is influenced by age, disease duration, sex and HLA-B<jats:sup>\u2217<\/jats:sup>27 status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>axPsA has not been properly defined hampering research into pathogenesis, disease impact and treatment. Research to define prevalence, clinical features, impact, similarities and differences with other axial SpA, and treatment is an unmet need.<\/jats:p><\/jats:sec>","DOI":"10.1097\/bor.0000000000000609","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:15:59Z","timestamp":1558754159000},"page":"329-334","source":"Crossref","is-referenced-by-count":42,"title":["Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?"],"prefix":"10.1097","volume":"31","author":[{"given":"Vinod","family":"Chandran","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine"},{"name":"Department of Laboratory Medicine and Pathobiology"},{"name":"Institute of Medical Science, University of Toronto"},{"name":"Krembil Research Institute, University Health Network, Toronto"},{"name":"Department of Medicine, Memorial University of Newfoundland, St. John's, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.2010.135889","article-title":"The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress","volume":"70","author":"Zeidler","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/rheumatology\/ket407","article-title":"Spondyloarthritis: from unifying concepts to improved treatment","volume":"53","author":"Paramarta","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20230829","first-page":"411","article-title":"Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis","volume":"46","author":"Lambert","year":"1977","journal-title":"Q J Med"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3899\/jrheum.090412","article-title":"Axial psoriatic arthritis: update on a longterm prospective study","volume":"36","author":"Chandran","year":"2009","journal-title":"J Rheumatol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11926-007-0074-2","article-title":"Axial disease in psoriatic arthritis","volume":"9","author":"Gladman","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1148\/108.1.9","article-title":"Psoriatic spondylitis","volume":"108","author":"Killebrew","year":"1973","journal-title":"Radiology"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/annrheumdis-2018-213334","article-title":"Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis","volume":"77","author":"Yap","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/ard.47.5.386","article-title":"Psoriatic spondyloarthropathy: a long term prospective study","volume":"47","author":"Hanly","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3899\/jrheum.091059","article-title":"Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis","volume":"37","author":"Chandran","year":"2010","journal-title":"J Rheumatol"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3899\/jrheum.171094","article-title":"Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona Psoriatic Arthritis\/Spondyloarthritis Registry","volume":"45","author":"Mease","year":"2018","journal-title":"J Rheumatol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/annrheumdis-2012-201884","article-title":"ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort","volume":"72","author":"van den Berg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R16-20230829","first-page":"2667","article-title":"Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors","volume":"28","author":"Brophy","year":"2001","journal-title":"J Rheumatol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s100670200003","article-title":"Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study","volume":"21","author":"Queiro","year":"2002","journal-title":"Clin Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jbspin.2007.11.005","article-title":"Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis","volume":"75","author":"Queiro","year":"2008","journal-title":"Joint Bone Spine"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/sarh.2002.33470","article-title":"Psoriatic spondyloarthropathy: a comparative study between HLA-B\u221727 positive and HLA-B\u221727 negative disease","volume":"31","author":"Queiro","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"R21-20230829","first-page":"1","article-title":"Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis","volume":"16","author":"Gladman","year":"1993","journal-title":"Clin Invest Med"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.57.3.135","article-title":"Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?","volume":"57","author":"Helliwell","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3899\/jrheum.101049","article-title":"Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease","volume":"38","author":"P\u00e9rez Alamino","year":"2011","journal-title":"J Rheumatol"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"e5652","DOI":"10.1097\/MD.0000000000005652","article-title":"Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort","volume":"95","author":"Landi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12891-016-0960-8","article-title":"Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study","volume":"27","author":"Lindstr\u00f6m","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"(Suppl)","key":"R27-20230829","first-page":"A114","volume":"77","author":"Coates","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/art.38050","article-title":"Magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA-B\u221727","volume":"65","author":"Castillo-Gallego","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/annrheumdis-2015-209068","article-title":"Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: posthoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1\/PSUMMIT-2)","volume":"75","author":"Kavanaugh","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","article-title":"Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13075-018-1565-4","article-title":"Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study","volume":"20","author":"Haroon","year":"2018","journal-title":"Arthritis Res Ther"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201907000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T22:13:25Z","timestamp":1694902405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201907000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000609","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}